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Fibrotic reactions in the skin are frequently preceded by in-
filtration of inflammatory cells and subsequent migration of 
fibroblastic cells . Interleukin-l is secreted by inflammatory 
cells and can regulate proliferation and protein synthesis of 
fibroblasts. Its role in fibrobl ast chemotaxis has not been 
elucidated in any detaiLUsing the well-established Boyden 
chamber assay for measurement of chemotaxis in vitro, we 
studied a wide range of recombinant human interleukin-1a 
concentrations to assess intrinsic chemotactic activity of in-
terleukin-la and to determine the capacity of this mediator 
to modify the chemotactic response of fibroblas ts to other 
chemoattractants. This was compared with the interleukin-
T he pivotal role of interleukin(IL)-l in inflammatory processes is well established (for review see [1,2]). The two subtypes IL-l a and IL-lp bind to the same recep-. tor and display similar spectra of effects [1,3 ,4]. These include induction of fever, neutrophilia, arthralgia, 
ferr ipenia, and acute-phase proteins on systemic application [1 ,5] 
and local in.flammatory reactions after subcutaneous injections [6,7]' 
The ability of IL-l to induce the expression of adhesion molecules 
[8,9] and to stimulate chemotaxis and activation of neutrophils and 
lymphocytic cells [5) may greatly contribute to its pro-inflamma-
tory effects in skin. IL-l-like activity in skin was found to be 
associated with epidermal cells [10,11) , but it is now clear that a 
range of resident as well as infiltrating inflammatory cells in the 
dermis participate in generating IL-l and respond to it [2). Dermal 
fibroblasts are induced by IL- l to increase their rate of proliferation 
and collagenase and collagen synthesis [12 - 14]. These are essential 
ac tivities during the repair phase of wound healing and in the in-
duction of fibrosis. Prior to that, however, fibrobl asts migrate into 
the wound bed in response to mediators released at the site of in-
fl ammation [15] . A variety of extracellular matrix components, 
such as fibronectin, collagen, and elastin, and certain of their frag-
ments are exposed and rearranged after tissue injury and have been 
identified as chemoattrac tants for fibroblasts [16 - 18]. Additionally, 
growth factors, such as platelet-derived growth factor (PDGF) [19) 
and epidermal growth factor (EGF) [20,21], induce fibroblast mi-
gration as well as proliferation. Fibroblasts themselves are capable of 
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1a dose required for enhancement of mRNA expression for 
collagenase. Although interleukin-la was not chemoattrac-
tive for fibroblasts, it specifically augmented migration 
toward fibroblast-conditioned medium and toward platelet-
derived growth factor but not toward epidermal growth fac-
tor, fibronectin, or transforming-growth factor-po Interleu-
kin-la did not measurably alter the expression of mRNA for 
the platelet-derived growth factor receptor or its platelet-
derived growth factor-binding characteristics. Doses re-
quired to enhance fibrobl as t chemotaxis were distinctly 
lower than those required for stimulation of collagenase 
mRNA expression.] Invest DermatoI100:780-784, 1993 
producing chemotactic substances for fibroblasts, as evidenced by 
the potent activity of medium from fibroblasts cultured in vitro [17]. 
Because IL-l is chemotactic for inflammatory cells, we elected to 
study the effects of IL-l on fibrobl ast chemotaxis and compared 
these with the regulation of collagenase synthesis. We show in this 
study that IL-l itself is not chemotactic for fibrobl asts but enhances 
fibroblas t chemotaxis toward PDGF. This effect is independent of 
the PDGF-binding characteristics and occurs at concentrations that 
are a hundredfold lower than those required for enhancement of 
collagenase production. 
MATERIALS AND METHODS 
Cell Culture and Incubation Conditions Human skin fibro-
blasts from healthy volunteers were obtained as described previ-
ously. The cells were cultured in Dulbecco's modified Eagle's me-
dium supplemented with 10% fetal bovine serum, 50 I1g/ml 
glutamine, 50 I1glml streptomycin, and 400 U/ml penicillin and 
were passaged at a split ratio of 1 : 2 using 0.1 % trypsin, 0.02% 
ethylenediamine tetraacetic acid in phosphate-buffered saline. Fi-
broblasts between passages 4 and 8 were washed with phosphate-
buffered saline and incubated for 24 or 48 h in fresh medium with 
or without addition of 0.001 - 100 U I ml recombinant human IL-
Ia (Boehringer Mannheim, Mannheim, Germany) (specific activ-
ity 8.5 X 107 U I mg). The cells were trypsinized as described above, 
counted in a hemocytometer, and used either for chemotaxis or 
preparation of total RNA. 
Chemoattractants Fibroblast-conditioned medium was ob-
tained by incubating confluent mono layers of fibroblasts with 
serum-free Dulbecco's modified Eagle's medium (10 ml/75 cm2 
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Figure 1. IL-1a pre-treatment augments chemotactic migration of fibro-
blasts toward fibrobl ast-conditioned medium. Human dermal fibroblasts 
were pre-incubated for 48 h with various concentrations of recombinant 
human IL-1a. Chemotaxis of these cells was assayed using fibroblast-condi-
tioned medium as attractant. Presented are mean values of four independent 
experiments in triplicate. SO was persistently below 15%. 
area) overnight. The supernatant was centrifuged to remove cell 
debris and used undiluted as chemoattractant. 
IL-1a that was used for pre-incubation of cells was also tested for 
intrinsic chemoattractant activity at concentrations between 0.001 
and 10 U/ ml. Recombinant human PDGF,_sis and radioactive 
(125I]PDGF (specific radioactivity 38 TBq/mmol) were obtained 
from Amersham (Braunschweig, Germany) . Recombinant human 
transforming growth factor-p (TGF-p) was supplied by Paesel 
(Frankfurt am Main, Germany), and highly purified EGF was from 
Seback (Aidenbach, Germany). Fibronectin was purified from 
human plasma by chromatography on heparin and gelatin Sephar-
ose and was kindly provided by H . Richter (Max-Planck-Institut fur 
Biochemie, Martinsried, Germany). 
Chemotaxis Assay This was performed as previously described 
[1 7] using blind-well Boyden chambers with polycarbonate filters 
(13-mrn diameter, pore size 8 J.lm) (Nuclepore, Tubingen, Ger-
many) _ The filters divided the chambers into a lower compartment 
containing the attractant (206 J.ll) and an upper compartment 
containing the cell suspension (750 J.ll, 2 X 105 cells/ml). The 
chambers were incubated at 37 °C for 4 h. The filters were col-
lected, and the cells were removed from the upper side of the mem-
branes_ Cells that had migrated to the lower face of the filters in 
response to the attractants were fixed and stained with methanol and 
eosin/hematoxilin, respectively. Migrated cells were counted in 
eight different fields per filter at magnification X 200. Three 
chambers were prepared for each sample. 
Determination of mRNA Expression for Collagenase and 
PDGF Receptor Confluent monolayers of fibroblasts were in-
cubated with or without IL- la, and total RNA was isolated by 
established procedures [22] . Briefly, the cells were rinsed twice with 
phospha te-buffered saline and then extracted with 5 M guanidine 
isothiocyanate. The extract was centrifuged through a 5.7 M CsCl 
cushion, and the pellet was washed with 80% ethanol and extracted 
with chloroform/phenol. RNA was precipitated with 70% ethanol, 
10 m.M sodium acetate and redissolved in 10 mM Tris(hydroxy-
methyl)aminomethane-HCl, 1 mM ethylenediamine tetraacetic 
acid, pH 7.4. The amount of total RNA was determined photome-
trically at 260 nm. For Northern blot analysis, 4 J.lg total RNA/lane 
was electrophoresed in 1 % agarose under denaturing conditions. 
RNAs "Were then transferred to nitrocellulose (Bio-Rad, Richmond, 
VA) _ For dot-blot analyses, serial dilutions of total RNA (5.0 -
0.3 J.l.g) were dotted onto nitrocellulose using a dot-blot apparatus. 
Filters "Were baked in a vacuum oven for 2 h at 80°C. Pre-hybridiza-
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Figure 2_ IL-1a pre-treatment augments the chemotactic migration of 
fibrobl asts toward POGF but not migration toward EGF, fibronectin, or 
TGF-p. Fibroblasts were pre-incubated without or with 10- 2 V/ml (0.117 
pg/ml) IL- l ex for 48 h. Chemotaxis of the ce lls was assayed using the follow-
ing attractants in Oulbecco's modified Eagle's medium: CM, fibroblast-con-
ditioned medium; EGF, epidermal growth factor (10 ng/ml); FN, fibronec-
tin (20 mg/ml); POGF, platelet-derived growth factor (0.2 V I ml); TGF-p, 
transforming growth factor-p (1 0 pg/ ml). 'Significant differences between 
the response of treated and untreated cells. 
tion was carried out for 3 h at 42 °C using 50% formamide, 50 mM 
sodium phosphate (pH 6.5), 5 X sod ium citrate/sodium chlOrIde 
buffer,S X Denhardt's solution, and 250 J.lg/ml salmon sperm 
DNA. Hybridization was carried out at 42°C for 12 h with [32P]la-
beled nick-translated cDNA in 50% formamide, 50 mM sodium 
phosphate (pH 6.5), 5 X sodium citrate/sodium chloride buffer, 
and 1 X Denhardt's so lution, 250 J.lg/ ml salmon sperm DNA [23]. 
The following clones were used: a 960-bp cDNA fragment corre-
spondmg to the 3'-terminal coding region of the PDGF receptor 
[24] , a 620-bp fragment corresponding to the coding sequence and 
the 3'-untranslated portion of collagenase RNA [25], and a 450-bp 
cDNA fragment of human p-actin [26] . The membranes were 
washed twice in 2 X sodium citrate/sodium chloride buffer, 0.1 % 
sod~um dodecyl sul fate at room temperature and twice in 0.1 % 
sodIUm citrate/sodium chloride buffer, 0.1 % sodium dodecyl sul-
fate at 62°C. Autoradiography was carried out with Kodak films 
(X-Omat AR) , and the films were developed and assessed densito-
metrically. 
Table I. Augmentation by Interleukin (IL)-l a of Chemotactic 
Migration of Fibroblasts Toward Platelet-Derived Growth Factor" 
Experiment 1 
Mean ± SO 
Experiment 2 
Mean ± SO 
Experiment 3 
Mean ± SO 
Number of Cells Migrated 
Control 
32 
48 
41 
40.3 ± 8.0 
98 
73 
81 
84.0 ± 12.8 
72 
76 
63 
70.3 ± 6.7 
IL-1 Treated 
52 
69 
64 
61.7 ± 8.7 
110 
127 
112 
116.3 ± 9.3 
82 
104 
91 
92.3 ± 11.1 
• Fibroblasts were incubated in three independent experiments for 48 h without 
(control) or with 10- 2 U j ml IL- l a (IL- l treated). Their chemotactic migration toward 
0.2 U j m! platelet-derived growth factor was assessed as described in Materials alld 
Methods. Differenccs between control and IL-l treated were statistically significant 111 all 
three experiments. 
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Figure 3. POGF binding to IL-IO' - treated fibroblasts. Binding of 
[, 25IjPDGF to proliferating (a) or contact-inhibited (b) cells pre-treated 
with IL-I01 (closed symbols) or not (open symbols) . The assay conditions are 
described in Materials atld Methods. 
PDGF Binding Assay Cells were trypsinized as above and 
seeded into 24-well plates (Costar) at a density of either 0.5 or 
2.5 X 105 cells/well in 500111 complete medium. The cells were 
allowed to attach overnight. The medium was replaced by complete 
medium with or without 0.1 U/ml IL-la, and incubation was 
continued for 48 h . A stock solution of[' 2SIjPDGF was prepared on 
ice as follows: to 1500111 binding medium (SOD ml Dulbecco's mod-
ified Eagle's medium containing 3 g N-[2-hydroxyethyljpipera-
zine-N'-[2-ethanesulfonic acidj, 500 mg bovine serum albumin, 
and 150 mg L-glutamine) was added lOl1g PDGF in 400111 1 M 
acetic acid. The pH was adjusted to neutral with approximately 
1001112.5 M NaOH, and to this was added 148 kBq l'2SIjPDGF in 
160111 binding medium. The solution thus contained unlabeled 
over labeled PDGF in excess of 100 times. The stock solution was 
diluted serially in twofold steps in binding medium. The cell layer 
was washed with warm phosphate-buffered saltne, and the wells 
received 150111 ice-cold binding medium and 100111 of the various 
PDGF solutions. The plates were incubated for 2 h on ice. Then, 
200111 supernatant was removed to determine unbound radioactiv-
ity. The cells were washed twice with cold Dulbecco's modified 
Eagle's medium and trypsinized with 250 Jll trypsin/ethylenedia-
mine tetraacetic acid solution. Radioactivity was determined in a 
200-Jll cell suspension. Cells in parallel wells that had not received 
radioactive material were likewise trypsinized and counted. 
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Figure 4. IL-I01 does not induce mRNA for the PDGF receptor. Fibro-
blasts were incubated for 48 h with various concentrations ofIL-IO' (U jml): 
latle 1, 0; latle 2, 0.01; lane 3, 0.1; lane 4, 1. Cells were either assayed for 
chemotaxis (data in Fig 2), or total RNA was extracted and assessed for the 
amount of mRNA for POGF receptor by Northern or dot-blot analysis using 
specific cDNA probes (see Materials atld Methods). 
Statistical Evaluation Mean values and standard deviations 
were calculated in all experiments. Data were compared by Student 
t test, with p :5 0 .05. 
RESULTS 
IL-la was tested for intrinsic chemotactic activity at concentrations 
between 10- 4 and 10 U /m!. No activity was detected, altl. _ .lgh the 
cells migrated normally to fibroblast-conditioned medium, which 
indicates their competence. The chemotactic response of fibroblasts 
to fibroblast-conditioned medium could be enhanced by pre-incu-
bating the indicator cells with IL-la. This effect was strictly dose 
dependent and more pronounced when the cells were pre-incubated 
for 48 h than for 24 h (Fig 1). IL-1a specifically stimulated chemo-
taxis, not random migration. This was demonstrated when IL··1a-
pre-treated cell were assayed in isotropic fields [i.e. , equal concen-
trations of the attractant in the lower and the upper compartments 
of the Boyden chambers (data not shown)j. 
Fibroblast-conditioned medium contains a variety of chemoat-
tractant substances for fibroblasts. However, fibroblasts will also 
respond to a number of well-defined growth factors, cytokines, and 
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Figure 5. Concentration dependence of the enhancing effect of IL-IOI on 
chemotaxis and collagenase mRNA expression. Fibroblasts were incubated 
for 48 h with the concentrations of IL-IO' indicated. Cells were either as-
sayed for chemotaxis. or total RNA was extracted and assessed for the 
amount of mRNA for collagenase (see Materials a"d Methods). Means and SOs 
of three experiments. 
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proteins of the extracellar matrix of connective tissues. We tested 
the effect of IL-la on the chemotactic migration of fibroblasts 
toward these classes of attractants using PDGF, EGF, TGF-fJ. and 
Jibronectin. IL-la strongly enhanced the response to PDGF, 
slightly stimulated migration toward EGF. and did not affect mi-
gration toward TGF-fJ or fibronectin (Fig 2) . Statistical evaluation 
of three independent experiments confirmed significant differences 
between IL-la-treated cells and controls with PDGF as attractant 
(Table I) but not with EGF. PDGF was used to explore whether 
JL-l Q al ters receptor characteristics for the attractant. There was no 
detectable increase in steady-state levels of mRNA for the PDGF 
receptor in IL-la-treated cells (Fig 3). Binding of (! 2SIjPDGF to 
fibroblasts was different on cells cultured at low density compared 
with high density but not on cells treated with IL-IO' or not (Fig 4). 
IL-l can stimulate synthesis of collagenase in fibroblasts [12] . We 
presume that the pleiotropic effects of most of the cytokines on a 
given type of cell may at least in part be explained by the strict dose 
dependency of the response of the target cell. It was therefore desir-
,hie to compare with the same kind of cells the IL-1O' concentration 
rhat most effectively augments chemotaxis to the concentrations 
required to activate collagenase synthesis. Maximal collagenase syn-
thesis occurred at approximately 100 U/ml IL-I (Fig 5). This is a 
concentration 100 times higher than that augmenting chemotaxis. 
Furthermore, whereas chemotaxis was increased only 1.5 times, 
collagenase synthesis was stimulated 4.5 times. 
DISCUSSION 
Directional migration of fibroblasts is an important feature during 
organization of the extracellular matrix of connective tissues and is 
therefore critically involved in development, in the repair phase of 
wound healing, and in the induction of fibrosis [27J. Sites of inflam-
mation are a particularly rich source of soluble mediators that may 
either attract fibrobl asts or modulate the chemotactic response of 
rhese cells. PDGF [19]. EGF [20,21], and TGF-fJ [28] are potent 
attractants, as are fragments of collagen and fibronectin that are 
released at inflammatory sites [16-18,27]. Some of the mediators 
are capable of modulating the migratory response of fibroblasts. We 
have previously shown that interferon-a and interferon-y can 
downregulate the chemotactic response of fibroblasts to growth 
factors and matrix proteins [29J and that TGF-fJ and POGF specifi-
cally inhibit chemotaxis to EGF [20] . 
IL-l is one of the more prominent mediators released in inflam-
matory situations, and its pleiotropic effects on fibroblasts are wel l 
documented [12-t4J. We now confirm that IL-1 is not intrinsically 
chemotactic. However, our data identify IL-l as the first cytokine 
that can enhance fibroblast chemotaxis. This effect is very specific. 
Of the attractants tested, only migration toward fibroblast-condi-
tioned medium and PDGF were significantly augmented by IL-1O' 
but not migration toward EGF, TGF-ft, or fibronectin. Enhance-
ment of chemotaxis to PDGF is apparently not mediated by alter-
ations of the PDGF receptor because IL-tO' affected neither the 
steady-state level of mRNA for the PDGF receptor nor the binding 
characteristics. One must therefore assume that IL-1a exerts its 
effects intracellularly and on the signal transduction pathway [1,3]. 
The enhancing effect of IL-1O' is strictly dose dependent. The 
dose/effect relationship is a bell-shaped curve that resembles the 
curves obtained for the chemoattractants themselves. We believe 
this to be biologically relevant because it may represent a mecha-
nism to fine-tune the activity of fibroblasts within the intricate 
regulatory networks connecting the inflammatory to the connec-
tive tissue system. 
It had been reported before that IL-l enhances fibroblast prolifera-
tion and synthesis of collagenase [12 - 14J. Our data show that stim-
ulation of collagenase synthesis requires a concentration of IL-ta 
approximately 100 times higher chan augmentation of chemotaxis. 
Fibroblasts relatively distant from the site of IL-tO' release may be 
exposed to a low concentration ofIL-la, and their PDGF-induced 
migration toward the inflammatory site could thus be augmented. 
The higher concentration of IL-ta at their destination may then 
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turn on the synthesis of collagenase. These mechanisms will cer-
tainly require further exploration. 
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